Tumor lysis syndrome induced by BRAF/MEK double blockade in a patient with metastatic melanoma: A first case report.

Tachibana, Kota; Ohe, Shuichi; Tanaka, Mari; Maniwa, Tomohiro; Isei, Taiki

Tachibana, Kota; Ohe, Shuichi; Tanaka, Mari; Maniwa, Tomohiro; Isei, Taiki.

Affiliation

Tachibana K; Department of Dermatologic Oncology, Osaka International Cancer Institute, Osaka, Japan.
Ohe S; Department of Dermatologic Oncology, Osaka International Cancer Institute, Osaka, Japan.
Tanaka M; Department of Dermatologic Oncology, Osaka International Cancer Institute, Osaka, Japan.
Maniwa T; Department of Thoracic Surgery, Osaka International Cancer Institute, Osaka, Japan.
Isei T; Department of Dermatologic Oncology, Osaka International Cancer Institute, Osaka, Japan.

J Dermatol ; 48(7): e324-e326, 2021 Jul.

Article in En | MEDLINE | ID: mdl-33990995

Subject(s)

Melanoma; Skin Neoplasms; Tumor Lysis Syndrome; Humans; Melanoma/drug therapy; Mitogen-Activated Protein Kinase Kinases; Protein Kinase Inhibitors/adverse effects; Proto-Oncogene Proteins B-raf/genetics; Skin Neoplasms/drug therapy; Tumor Lysis Syndrome/diagnosis; Tumor Lysis Syndrome/etiology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Tumor Lysis Syndrome / Melanoma Type of study: Diagnostic_studies / Etiology_studies Limits: Humans Language: En Journal: J Dermatol Year: 2021 Document type: Article Affiliation country: Japan Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google